Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on rapid, non-invasive testing solutions, has announced its participation in the upcoming Sidoti Micro-Cap Virtual Conference. The company's management team will present on Thursday, August 21, 2025, at 9:15 a.m. Eastern Time.
Investors can access the presentation through a webcast link and schedule one-on-one meetings with management through Sidoti representatives or KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), una società di tecnologia medica specializzata in soluzioni di test rapidi e non invasive, ha annunciato la sua partecipazione al prossimo Sidoti Micro-Cap Virtual Conference. Il team di gestione presenterà giovedì 21 agosto 2025, alle 9:15 (Eastern Time).
Gli investitori potranno seguire la presentazione tramite un link alla trasmissione web e prenotare incontri individuali con il management tramite i rappresentanti di Sidoti o KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), una empresa de tecnología médica centrada en soluciones de pruebas rápidas y no invasivas, ha anunciado su participación en la próxima Sidoti Micro-Cap Virtual Conference. El equipo directivo presentará el jueves 21 de agosto de 2025 a las 9:15 a.m. (Eastern Time).
Los inversores podrán acceder a la presentación mediante un enlace de webcast y concertar reuniones individuales con la dirección a través de los representantes de Sidoti o de KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS)는 신속하고 비침습적인 검사 솔루션에 주력하는 의료기술 기업으로, 다가오는 Sidoti Micro-Cap Virtual Conference에 참가한다고 발표했습니다. 회사 경영진은 2025년 8월 21일 목요일 오전 9시 15분 (Eastern Time)에 발표를 진행합니다.
투자자는 웹캐스트 링크를 통해 발표를 시청할 수 있으며 Sidoti 담당자나 KCSA Strategic Communications를 통해 경영진과의 일대일 미팅을 예약할 수 있습니다.
Intelligent Bio Solutions (Nasdaq: INBS), une entreprise de technologie médicale spécialisée dans les solutions de tests rapides et non invasifs, a annoncé sa participation à la prochaine Sidoti Micro-Cap Virtual Conference. L'équipe de direction présentera le jeudi 21 août 2025 à 9h15 (Eastern Time).
Les investisseurs pourront accéder à la présentation via un lien de webdiffusion et organiser des réunions individuelles avec la direction par l'intermédiaire des représentants de Sidoti ou de KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), ein Medizintechnikunternehmen, das sich auf schnelle, nicht-invasive Testlösungen spezialisiert hat, hat seine Teilnahme an der kommenden Sidoti Micro-Cap Virtual Conference angekündigt. Das Managementteam wird am Donnerstag, den 21. August 2025 um 9:15 Uhr (Eastern Time) präsentieren.
Investoren können die Präsentation über einen Webcast-Link verfolgen und Einzelgespräche mit dem Management über Sidoti-Vertreter oder KCSA Strategic Communications vereinbaren.
- None.
- None.
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced that its management team will participate in the Sidoti Micro-Cap Virtual Conference being held on August 20-21, 2025.
Presentation Details
Date: Thursday, August 21, 2025
Time: 9:15 a.m. Eastern Time
Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_ieBPBZr5S6W13jJgAxWOoQ
For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Sidoti representative or email KCSA Strategic Communications at INBS@ksca.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When is Intelligent Bio Solutions (INBS) presenting at the Sidoti Micro-Cap Conference?
How can investors attend the INBS Sidoti conference presentation?
How can investors schedule meetings with INBS management at the Sidoti conference?
What does Intelligent Bio Solutions (INBS) company do?
